Daxor Corporation

Healthcare

NASDAQ:DXR · NASDAQ Capital Market

Market Cap $50.66M Beta 0.26 P/E (TTM) 5.5

$10.00 +3.41%

+$0.33 today

52W Low $8.56High $14.76

Vol 0.00M · Avg 0.01M

EPS (TTM) $1.81Medical - Instruments & Supplies

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+5.71%

Period High

$14.75

Period Low

$8.87

Latest

$10.00

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Adagene Inc.

NASDAQ:ADAG

$132.15M

Gain Therapeutics, Inc.

NASDAQ:GANX

$76.35M

Great Elm Group, Inc.

NASDAQ:GEG

$73.69M

Adicet Bio, Inc.

NASDAQ:ACET

$72.54M

XBiotech Inc.

NASDAQ:XBIT

$71.65M

NRx Pharmaceuticals, Inc.

NASDAQ:NRXP

$68.62M

CervoMed Inc.

CRVO

$41.85M

Nephros, Inc.

NEPH

$34.63M

Lite Strategy, Inc.

LITS

$31.30M

HeartBeam, Inc.

BEAT

$24.94M

What is the latest DXR filing?

The latest filing shown is DEF 14A dated Jun 3, 2026.

How many recent filings does DXR have?

Intrinsic Alpha currently shows 20 recent filings for DXR.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.